Vol 12, No 12 (December 26, 2023): Translational Lung Cancer Research

Editorial

Immunotherapy: remember the host
Paul R. Walker
Translational Lung Cancer Research  
2023;
12
(12)
:2366-2369
.

Original Article

Cathepsin detection to identify malignant cells during robotic pulmonary resection
Patrick Bou-Samra, Austin Chang, Emily Guo, Feredun Azari, Gregory Kennedy, John T. Santini Jr, Eric S. Bensen, Doraid Jarrar, Sunil Singhal
Translational Lung Cancer Research  
2023;
12
(12)
:2370-2380
.
Comparison of different maintenance regimens following first-line immunochemotherapy for advanced non-small cell lung cancer
Feng Li, Huiting Wang, Yang Xiang, Run Li, Caichen Li, Ran Zhong, Jianfu Li, Shan Xiong, Lixian Liang, Jianxing He, Wenhua Liang
Translational Lung Cancer Research  
2023;
12
(12)
:2381-2391
.
A collection of multiregistry data on patients at high risk of lung cancer—a Danish retrospective cohort study of nearly 40,000 patients
Margrethe Bang Henriksen, Torben Frøstrup Hansen, Lars Henrik Jensen, Claus Lohman Brasen, Abdolrahman Peimankar, Ali Ebrahimi, Uffe Kock Wiil, Ole Hilberg
Translational Lung Cancer Research  
2023;
12
(12)
:2392-2411
.
Does subtyping of high-grade pulmonary neuroendocrine carcinomas have an impact on therapy selection?
Helmut Popper, Luka Brcic, Sylvia Eidenhammer
Translational Lung Cancer Research  
2023;
12
(12)
:2412-2426
.
Antibiotic treatment and survival in non-small cell lung cancer patients receiving immunotherapy: a systematic review and meta-analysis
Arwa Abdelhamid, Stephanie Tuminello, Tara Ivic-Pavlicic, Raja Flores, Emanuela Taioli
Translational Lung Cancer Research  
2023;
12
(12)
:2427-2439
.
Clinical characteristics and progression of pre-/minimally invasive lung adenocarcinoma harboring ALK or RET rearrangements: a retrospective cohort study
Chaoqiang Deng, Zongwei Chen, Jinsong Bai, Fangqiu Fu, Shengping Wang, Yuan Li, Yang Zhang, Haiquan Chen
Translational Lung Cancer Research  
2023;
12
(12)
:2440-2447
.
Effectiveness and safety of amivantamab in EGFR exon 20 insertion (E20I) mutations in non-small cell lung cancer (NSCLC)
Dae-Ho Choi, Hyun Ae Jung, Sehhoon Park, Jong-Mu Sun, Jin Seok Ahn, Myung-Ju Ahn, Se-Hoon Lee
Translational Lung Cancer Research  
2023;
12
(12)
:2448-2459
.
Serum-based biomarkers associated with lung cancer risk and cause-specific mortality in the German randomized Lung Cancer Screening Intervention (LUSI) trial
Francisco O. Cortés-Ibáñez, Theron Johnson, Mario Mascalchi, Verena Katzke, Stefan Delorme, Rudolf Kaaks
Translational Lung Cancer Research  
2023;
12
(12)
:2460-2475
.
Prognostic value and immune regulatory role of dynamin 1-like in lung adenocarcinoma
Wenping Song, Xuan Wu, Shuai Wang, Martin P. Barr, María Rodríguez, In-Jae Oh, Yingxi Wu, Ding Li
Translational Lung Cancer Research  
2023;
12
(12)
:2476-2493
.
Deep learning-assisted development and validation of an algorithm for predicting the growth of persistent pure ground-glass nodules
Yanhua Tang, Minzhen Li, Benke Lin, Xuemin Tao, Zhongyue Shi, Xin Jin, Stefano Bongiolatti, Sara Ricciardi, Duilio Divisi, Marion Durand, Houssein A. Youness, Shuichi Shinohara, Chuang Zhu, Yi Liu
Translational Lung Cancer Research  
2023;
12
(12)
:2494-2504
.
Efficacy of alectinib in lung adenocarcinoma patients with different anaplastic lymphoma kinase (ALK) rearrangements and co-existing alterations—a retrospective cohort study
Jiaqi Li, Kuofang Huang, Hao Ji, Jialin Qian, Haijiao Lu, Yanan Zhang, Alessandro Russo, Atocha Romero, Edyta Maria Urbanska, Fabrizio Tabbò, Xiaoyu Zhao, Tianqing Chu
Translational Lung Cancer Research  
2023;
12
(12)
:2505-2519
.
Exosomal ITGB6 from dormant lung adenocarcinoma cells activates cancer-associated fibroblasts by KLF10 positive feedback loop and the TGF-β pathway
Xiang Feng, Xianling Liu, Juanjuan Xiang, Jiaqi Xu, Na Yin, Lujuan Wang, Chaoyuan Liu, Yuyao Liu, Tiantian Zhao, Zengyi Zhao, Yawen Gao
Translational Lung Cancer Research  
2023;
12
(12)
:2520-2537
.

Case Report: iMDT Corner

An advanced NSCLC patient with ALK-RNF144A and HIP1-ALK fusions treated with ALK-TKI combination therapy: a case report
Hui Li, Jingjing Liu, Shaowei Lan, Rui Zhong, Yanan Cui, Petros Christopoulos, Erin L. Schenk, Takaaki Sasaki, Ying Cheng
Translational Lung Cancer Research  
2023;
12
(12)
:2538-2549
.

Case Report

Tract creation with a 25-gauge needle for convex endobronchial ultrasound-guided core biopsy in intrapulmonary lesions adjacent to bronchi: three case reports
Hiroaki Nagamine, Toshiyuki Nakai, Takahiro Ueda, Kenji Nakahama, Kenji Sawa, Kazuhiro Yamada, Tetsuya Watanabe, Kazuhisa Aasai, Tomoya Kawaguchi
Translational Lung Cancer Research  
2023;
12
(12)
:2550-2557
.
Combinatorial therapy is a safe and durable treatment option in ALK-rearranged non-small cell lung cancer with an acquired MET exon 14 skipping mutation mediated resistance to alectinib: a case report
Charley Jang, Joshua Sabari
Translational Lung Cancer Research  
2023;
12
(12)
:2558-2564
.

Editorial Commentary

Can liquid biopsy dynamics stratify patients with small cell lung cancer?
Christoffer T. Maansson, Peter Meldgaard, Boe Sandahl Sorensen
Translational Lung Cancer Research  
2023;
12
(12)
:2565-2569
.
eIF4A dependency: the hidden key to unlock KRAS mutant non-small cell lung cancer’s vulnerability
Silvia Casacuberta-Serra, Iñigo Gonzalez-Larreategui, Laura Soucek
Translational Lung Cancer Research  
2023;
12
(12)
:2570-2575
.